share_log

AnPac Bio Announces Board and Management Changes,

AnPac Bio Announces Board and Management Changes,

Anpac Bio 宣布董事会和管理层变动,
Benzinga Real-time News ·  2022/10/03 17:21
AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) ("AnPac Bio" or the "Company"), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced changes to its board composition and management team.
在美国有业务、中国专注于癌症早期筛查和检测的生物技术公司安派科股份有限公司(纳斯达克股票代码:ANPC)(以下简称:安派克生物)今天宣布对其董事会组成和管理团队进行变动。
Mr. Haohan Xu has been appointed as a director of the board of directors (the "Board"), Co-Chairperson of the Board and Co-Chief Executive Officer of the Company. Mr. Xu is the Chief Executive Officer of Apifiny Group Inc., a digital asset trading infrastructure provider based in New York, United States and has been actively engaged in the...
徐浩汉先生已获委任为董事董事会(“董事会”)董事、董事会联席主席及联席行政总裁。徐先生是总部位于美国纽约的数字资产交易...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发